THIS CLINICAL ANSWER IS UPDATED
This Cochrane Clinical Answer compares vascular endothelial growth factor (VEGF) drugs versus conventional laser therapy for treatment of people with retinopathy of prematurity.
Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.
A subscription to THE COCHRANE LIBRARY is required.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.